ACT Methylphenidate ER (2020-02-07)

Starting date:
February 7, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-72305

Last updated:

Summary

  • Product: ACT Methylphenidate ER 18 mg Tablet

Reason

Affected lot(s) may be missing the desiccant.

Depth of distribution

Wholesalers, Healthcare Establishments, Retailers

Affected products

ACT Methylphenidate ER 18 mg Tablet

DIN, NPN, DIN-HIM

DIN 02441934

Dosage form

Tablet (Extended-Release)

Strength

Methylphenidate hydrochloride 18 mg

Lot or serial number

1293319A

Companies

Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA